Header Logo

Connection

ANDREW CIVITELLO to Humans

Back to Details
This is a "connection" page, showing publications ANDREW CIVITELLO has written about Humans.
ANDREW CIVITELLO
Connection Strength
0.385
Humans
  1. Simultaneous Heart-Kidney Transplantation: Balancing Competing Outcomes for Transplant Wait-Listed?Patients. J Am Coll Cardiol. 2023 02 28; 81(8):741-742.
    View in: PubMed
    Score: 0.023
  2. Toward a Self-Actuating Continuous Flow Ventricular Assist Device: The Pudding Is in the Proof. ASAIO J. 2023 01 01; 69(1):59-60.
    View in: PubMed
    Score: 0.023
  3. Impact of time off anticoagulation in patients with continuous-flow left ventricular assist devices. J Artif Organs. 2023 Dec; 26(4):275-286.
    View in: PubMed
    Score: 0.023
  4. Incidental diagnosis of interrupted aortic arch in a 72-year-old man. Tex Heart Inst J. 2009; 36(5):494-5.
    View in: PubMed
    Score: 0.009
  5. Use of a percutaneous ventricular assist device for treatment of cardiogenic shock due to critical aortic stenosis. Tex Heart Inst J. 2006; 33(4):487-9.
    View in: PubMed
    Score: 0.007
  6. Medium to long-term ventricular assist device support in adults with congenital heart disease. J Heart Lung Transplant. 2025 Feb; 44(2):278-281.
    View in: PubMed
    Score: 0.007
  7. Mortality in Recipients of Durable Left Ventricular Assist Devices Undergoing Ventricular Tachycardia Ablation. JACC Clin Electrophysiol. 2024 Sep; 10(9):2049-2058.
    View in: PubMed
    Score: 0.006
  8. Kidney Function Trajectories and Right Heart Failure Following LVAD Implantation. J Am Heart Assoc. 2024 Mar 05; 13(5):e031305.
    View in: PubMed
    Score: 0.006
  9. Patients' and physicians' beliefs and attitudes towards integrating personalized risk estimates into patient education about left ventricular assist device therapy. Patient Educ Couns. 2024 May; 122:108157.
    View in: PubMed
    Score: 0.006
  10. Sex Disparities in Left Ventricular Assist Device Implantation: Delayed Presentation and Worse Right Heart Failure. ASAIO J. 2024 06 01; 70(6):469-476.
    View in: PubMed
    Score: 0.006
  11. Clinical Predictors and Outcomes After Left Ventricular Assist Device Implantation and Tracheostomy. Tex Heart Inst J. 2023 08 22; 50(4).
    View in: PubMed
    Score: 0.006
  12. Impact of the 2018 UNOS Heart?Transplant Policy Changes on?Patient?Outcomes. JACC Heart Fail. 2023 05; 11(5):491-503.
    View in: PubMed
    Score: 0.006
  13. Continuous-Flow Ventricular Assist Device Support in Adult Congenital Heart Disease: A 15-Year, Multicenter Experience of Temporary and Durable Support. ASAIO J. 2023 05 01; 69(5):429-437.
    View in: PubMed
    Score: 0.006
  14. Distinctive kidney function trajectories following left ventricular assist device implantation. J Heart Lung Transplant. 2022 12; 41(12):1798-1807.
    View in: PubMed
    Score: 0.006
  15. Key Concepts Surrounding Cardiogenic Shock. Curr Probl Cardiol. 2022 Nov; 47(11):101303.
    View in: PubMed
    Score: 0.006
  16. Preoperative hyponatremia and survival after left ventricular assist device implantation. Artif Organs. 2022 Sep; 46(9):1923-1931.
    View in: PubMed
    Score: 0.006
  17. The influence of preoperative dialysis on survival after continuous-flow left ventricular assist device implantation. Interact Cardiovasc Thorac Surg. 2022 02 21; 34(3):470-477.
    View in: PubMed
    Score: 0.005
  18. Nephrology Considerations in the Management of Durable and Temporary Mechanical Circulatory Support. Kidney360. 2022 03 31; 3(3):569-579.
    View in: PubMed
    Score: 0.005
  19. Left Ventricular Unloading During Extracorporeal Life Support: Current Practice. J Card Fail. 2022 08; 28(8):1326-1336.
    View in: PubMed
    Score: 0.005
  20. Continuous-Flow Left Ventricular Assist Device Support in Patients with Ischemic Versus Nonischemic Cardiomyopathy. Tex Heart Inst J. 2021 Sep 01; 48(4).
    View in: PubMed
    Score: 0.005
  21. Genetic testing in ambulatory cardiology clinics reveals high rate of findings with clinical management implications. Genet Med. 2021 12; 23(12):2404-2414.
    View in: PubMed
    Score: 0.005
  22. Continuous-Flow Left Ventricular Assist Device Explantation After More Than 5 Years of Circulatory Support and Ventricular Reconditioning. Tex Heart Inst J. 2021 06 10; 48(2).
    View in: PubMed
    Score: 0.005
  23. Extracorporeal membrane oxygenation as a bridge to durable left ventricular assist device implantation in INTERMACS-1 patients. J Artif Organs. 2022 Mar; 25(1):16-23.
    View in: PubMed
    Score: 0.005
  24. A principal components analysis of factors associated with successful implementation of an LVAD decision support tool. BMC Med Inform Decis Mak. 2021 03 20; 21(1):106.
    View in: PubMed
    Score: 0.005
  25. Predictors of renal replacement therapy in patients with continuous flow left ventricular assist devices. J Artif Organs. 2021 Jun; 24(2):207-216.
    View in: PubMed
    Score: 0.005
  26. Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure: Results From the EMBRACE-HF Trial. Circulation. 2021 04 27; 143(17):1673-1686.
    View in: PubMed
    Score: 0.005
  27. Survival on the Heart Transplant Waiting List. JAMA Cardiol. 2020 11 01; 5(11):1227-1235.
    View in: PubMed
    Score: 0.005
  28. Donor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic. Am J Transplant. 2020 11; 20(11):3113-3122.
    View in: PubMed
    Score: 0.005
  29. Accuracy of Postoperative Risk Scores for Survival Prediction in Interagency Registry for Mechanically Assisted Circulatory Support Profile 1 Continuous-Flow Left Ventricular Assist Device Recipients. ASAIO J. 2020 05; 66(5):539-546.
    View in: PubMed
    Score: 0.005
  30. Gastrointestinal Bleeding After HeartMate II or HVAD Implantation: Incidence, Location, Etiology, and Effect on Survival. ASAIO J. 2020 03; 66(3):283-290.
    View in: PubMed
    Score: 0.005
  31. Outcomes of Repeat Left Ventricular Assist Device Exchange. ASAIO J. 2020 01; 66(1):64-68.
    View in: PubMed
    Score: 0.005
  32. Effect of cardiac arrest with aortic cross-clamping during left ventricular assist device implantation. Interact Cardiovasc Thorac Surg. 2020 01 01; 30(1):47-53.
    View in: PubMed
    Score: 0.005
  33. Plasmapheresis in Patients With Heparin-induced Thrombocytopenia Requiring Ventricular Assist Device. Ann Thorac Surg. 2020 06; 109(6):e439-e440.
    View in: PubMed
    Score: 0.005
  34. Long-Term Continuous-Flow Left Ventricular Assist Device Support After Left Ventricular Outflow Tract Closure. ASAIO J. 2019 08; 65(6):558-564.
    View in: PubMed
    Score: 0.005
  35. Concomitant valve procedures in patients undergoing continuous-flow left ventricular assist device implantation: A single-center experience. J Thorac Cardiovasc Surg. 2019 10; 158(4):1083-1089.e1.
    View in: PubMed
    Score: 0.004
  36. Severe LVAD-related infections requiring surgical treatment: Incidence, predictors, effect on survival, and impact of device selection. J Card Surg. 2019 Feb; 34(2):82-91.
    View in: PubMed
    Score: 0.004
  37. A left ventricular end-diastolic dimension less than 6.0?cm is associated with mortality after implantation of an axial-flow pump. J Thorac Cardiovasc Surg. 2019 06; 157(6):2302-2310.
    View in: PubMed
    Score: 0.004
  38. Fatal Neurologic Dysfunction During Continuous-Flow Left Ventricular Assist Device Support. Ann Thorac Surg. 2019 04; 107(4):1132-1138.
    View in: PubMed
    Score: 0.004
  39. A Multisite Randomized Controlled Trial of a Patient-Centered Ventricular Assist Device Decision Aid (VADDA Trial). J Card Fail. 2018 Oct; 24(10):661-671.
    View in: PubMed
    Score: 0.004
  40. Effect of Preoperative Atrial Fibrillation on Patients with Chronic Heart Failure Who Undergo Long-Term Continuous-Flow LVAD Implantation. ASAIO J. 2018 Sep-Oct; 64(5):594-600.
    View in: PubMed
    Score: 0.004
  41. Left Ventricular Recovery with Explantation of Continuous-Flow Left Ventricular Assist Device after 5 Years of Support. Ann Thorac Cardiovasc Surg. 2021 Jun 20; 27(3):211-214.
    View in: PubMed
    Score: 0.004
  42. Continuous-Flow Left Ventricular Assist Device Therapy in Adults with Transposition of the Great Vessels. Ann Thorac Cardiovasc Surg. 2021 Feb 20; 27(1):64-67.
    View in: PubMed
    Score: 0.004
  43. Predictive value of preoperative serum albumin levels on outcomes in patients undergoing LVAD implantation. J Card Surg. 2018 Aug; 33(8):469-478.
    View in: PubMed
    Score: 0.004
  44. Use of Remote Pulmonary Artery Pressure Monitoring (CardioMEMS System) in Total Artificial Heart to Assess Pulmonary Hemodynamics for Heart Transplantation. ASAIO J. 2018 Jul/Aug; 64(4):e75-e77.
    View in: PubMed
    Score: 0.004
  45. Effect of obesity on outcomes in patients who undergo implantation of a continuous-flow left ventricular assist device. J Artif Organs. 2018 09; 21(3):397.
    View in: PubMed
    Score: 0.004
  46. HeartMate II implantation technique that spares the sternum and ascending aorta. J Artif Organs. 2018 Dec; 21(4):458-461.
    View in: PubMed
    Score: 0.004
  47. Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices. J Artif Organs. 2018 Sep; 21(3):285-292.
    View in: PubMed
    Score: 0.004
  48. Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2018 08; 106(2):513-519.
    View in: PubMed
    Score: 0.004
  49. Bridging to a Long-Term Ventricular Assist Device With Short-Term Mechanical Circulatory Support. Artif Organs. 2018 Jun; 42(6):589-596.
    View in: PubMed
    Score: 0.004
  50. Effect of obesity on outcomes in patients undergoing implantation of continuous-flow left ventricular assist devices. J Artif Organs. 2018 Jun; 21(2):180-187.
    View in: PubMed
    Score: 0.004
  51. Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle. Ann Thorac Surg. 2018 03; 105(3):799-806.
    View in: PubMed
    Score: 0.004
  52. Incidence, Predictors, and Significance of?Ventricular Arrhythmias in Patients With?Continuous-Flow Left Ventricular Assist Devices: A 15-Year Institutional Experience. JACC Clin Electrophysiol. 2018 02; 4(2):257-264.
    View in: PubMed
    Score: 0.004
  53. Frequency and Consequences of Right-Sided Heart Failure After Continuous-Flow Left Ventricular Assist Device Implantation. Am J Cardiol. 2018 02 01; 121(3):336-342.
    View in: PubMed
    Score: 0.004
  54. Left ventricular outflow tract closure during LVAD implantation: 2 cases of patients supported for over 6?years. J Artif Organs. 2017 Dec; 20(4):350-353.
    View in: PubMed
    Score: 0.004
  55. Outcomes in patients with advanced heart failure and small body size undergoing continuous-flow left ventricular assist device implantation. J Artif Organs. 2018 Mar; 21(1):31-38.
    View in: PubMed
    Score: 0.004
  56. Preoperative Prealbumin Level as a Predictor of Outcomes in Patients Who Underwent Left Ventricular Assist Device Implantation. Am J Cardiol. 2017 Dec 01; 120(11):1998-2002.
    View in: PubMed
    Score: 0.004
  57. Total artificial heart implantation for biventricular failure due to eosinophilic myocarditis. J Artif Organs. 2017 Sep; 20(3):266-269.
    View in: PubMed
    Score: 0.004
  58. Perforation of a HeartMate II outflow graft. J Card Surg. 2017 Mar; 32(3):233-234.
    View in: PubMed
    Score: 0.004
  59. Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol. 2017 Jan; 48(1):27-34.
    View in: PubMed
    Score: 0.004
  60. Improved systemic saturation after ventricular assist device implantation in a patient with decompensated dextro-transposition of the great arteries after the Fontan procedure. Tex Heart Inst J. 2015 Feb; 42(1):40-3.
    View in: PubMed
    Score: 0.003
  61. Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure. J Thorac Cardiovasc Surg. 2015 Jan; 149(1):267-75, 278.e1.
    View in: PubMed
    Score: 0.003
  62. Association between cell-derived microparticles and adverse events in patients with nonpulsatile left ventricular assist devices. J Heart Lung Transplant. 2014 May; 33(5):470-7.
    View in: PubMed
    Score: 0.003
  63. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol. 2014 Feb; 27(1):1-11.
    View in: PubMed
    Score: 0.003
  64. Trauma in patients with continuous-flow left ventricular assist devices. Am J Cardiol. 2013 Nov 01; 112(9):1520-2.
    View in: PubMed
    Score: 0.003
  65. Bivalirudin for treatment of aortic valve thrombosis after left ventricular assist device implantation. ASAIO J. 2013 Jul-Aug; 59(4):448-9.
    View in: PubMed
    Score: 0.003
  66. Percutaneous ventricular assist device in hypertrophic obstructive cardiomyopathy with cardiogenic shock: bridge to myectomy. Ann Thorac Surg. 2012 Mar; 93(3):978-80.
    View in: PubMed
    Score: 0.003
  67. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv. 2009 Feb; 2(2):91-6.
    View in: PubMed
    Score: 0.002
  68. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. J Heart Lung Transplant. 2008 Jan; 27(1):106-11.
    View in: PubMed
    Score: 0.002
  69. Use of the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol. 2006 Mar; 18(3):93-6.
    View in: PubMed
    Score: 0.002
  70. Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J. 2006; 33(2):111-5.
    View in: PubMed
    Score: 0.002
  71. Unprotected left main stent placement in a patient with Takayasu's arteritis: an unusual solution for an unusual disease. Tex Heart Inst J. 2006; 33(2):253-5.
    View in: PubMed
    Score: 0.002
  72. Arrhythmogenic right ventricular dysplasia: initial presentation in a middle-aged woman. Tex Heart Inst J. 2006; 33(3):386-8.
    View in: PubMed
    Score: 0.002
  73. Hemodynamic support with a percutaneous left ventricular assist device during stenting of an unprotected left main coronary artery. Tex Heart Inst J. 2004; 31(1):84-6.
    View in: PubMed
    Score: 0.002
  74. Cardiac tamponade and electrical alternans. Tex Heart Inst J. 2002; 29(1):66-7.
    View in: PubMed
    Score: 0.001
  75. DNA typing and genetic mapping with trimeric and tetrameric tandem repeats. Am J Hum Genet. 1991 Oct; 49(4):746-56.
    View in: PubMed
    Score: 0.001
  76. Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families. Genomics. 1990 Jun; 7(2):235-44.
    View in: PubMed
    Score: 0.001
  77. Automated DNA sequencing of the human HPRT locus. Genomics. 1990 Apr; 6(4):593-608.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.